More Information
Summary:This invention provides a method for preventing or treating Severe Acute Respiratory Syndrome in a subject comprising administering to the subject an effective amount of recombinant super-compound interferon or a functional equivalent thereof. This invention provides a method for inhibiting the causative agent of Severe Acute Respiratory Syndrome comprising contacting t he agent with an effective amount of super-compound interferon or its equivalen t.
Bibliography:Application Number: CA20042535982